Showing results (101-110 of 199) with videos related to

Sort By:
Pageof 20
Molecular Therapy Oncolytics|September 1, 2017
Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor ModelsFabrice Le Boeuf, Simon Gebremeskel, Nichole McMullen, et al.
Plos One|September 21, 2011
A selectable and excisable marker system for the rapid creation of recombinant poxvirusesJulia L Rintoul, Jiahu Wang, Don B Gammon, et al.
Science Translational Medicine|January 26, 2018
Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibitionMohammed Selman, Paula Ou, Christopher Rousso, et al.
Biosensors & Bioelectronics|March 11, 2021
SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognitionTaha Azad, Ragunath Singaravelu, Emily E F Fekete, et al.
Plos One|January 13, 2010
Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude miceJari E Heikkilä, Markus J V Vähä-Koskela, Janne J Ruotsalainen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitizationScott A Laurie, John C Bell, Harold L Atkins, et al.
Molecular and Cellular Biology|October 13, 2006
Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stressJaime D Blais, Christina L Addison, Robert Edge, et al.
Molecular Therapy Oncolytics|June 18, 2021
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancerHans Martin Singh, Mathias Felix Leber, Sascha Bossow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumorsYushui Wu, Xueqing Lun, Hongyuan Zhou, et al.
Circulation|January 28, 2014
Double-stranded RNA-dependent protein kinase deficiency protects the heart from systolic overload-induced congestive heart failureHuan Wang, Xin Xu, John Fassett, et al.
Pageof 20